Cite
HARVARD Citation
Witjes, H. et al. (2020). Meta‐Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority. Clinical pharmacology & therapeutics. 107 (2), pp. 435-442. [Online].